Jon K. Reel

Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain

Harry F. Dovey, Varghese John, J. P. Anderson et al. · Journal of Neurochemistry · 2001 · 879 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Substituted 3-Imidazo[1,2-<i>a</i>]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino- [6,7,1-<i>hi</i>]indol-7-yl)pyrrole-2,5-diones as Highly Selective and Potent Inhibitors of Glycogen Synthase Kinase-3

Thomas A. Engler, James R. Henry, Sushant Malhotra et al. · Journal of Medicinal Chemistry · 2004 · 102 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.

D M Zimmerman, J. David Leander, Jon K. Reel et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 97 citations

Medicine, Pharmacology, Neuropharmacology +15

Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism

Akihiko Kato, Kevin D. Burris, Kevin M. Gardinier et al. · Nature Medicine · 2016 · 90 citations · Full text

Life Sciences, Neuroscience, Pharmacology +16

Non-peptide angiotensin II receptor antagonists discriminate subtypes of 125I-angiotensin II binding sites in the rat brain

Donald R. Gehlert, Susan L. Gackenheimer, Jon K. Reel et al. · European Journal of Pharmacology · 1990 · 73 citations

Medicine, Neuroscience, Pharmacology +8